COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

RecruitingOBSERVATIONAL
Enrollment

27,000

Participants

Timeline

Start Date

December 24, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2026

Conditions
Covid19
Interventions
DRUG

Coromec Registry with ECL-19

Glycocheck to assess Microvascular Score will be used on all patients. An algorithm-based identification of symptoms and objective evidence using care coordination and remote sensor driven technology

Trial Locations (3)

85016

RECRUITING

Multiple Locations, Phoenix

Unknown

RECRUITING

Multiple Locations, Bangalore

RECRUITING

Multiple Locations, Stockholm

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Intel Corporation

INDUSTRY

collaborator

Abrazo Health Network

UNKNOWN

collaborator

Karolinska Institutet

OTHER

collaborator

ASU College of Health Solutions

UNKNOWN

lead

Aventyn, Inc.

INDUSTRY